RFP
PRAX icon

Root Financial Partners’s Praxis Precision Medicines PRAX Stock Holding History

Root Financial Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25K Buy
+7
New +$2.17K ﹤0.01% 2269

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Root Financial Partners's PRAX Position: Q1 2026 in Review

Root Financial Partners opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 7 shares worth $2.25K. The stake represents ﹤0.01% of the portfolio and ranks #2269 among its holdings.

289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Root Financial Partners held 7 shares of Praxis Precision Medicines worth $2.25K as of Q1 2026.
  • Praxis Precision Medicines was a new Root Financial Partners position in Q1 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2269 holding.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.